Viewing Study NCT02764593


Ignite Creation Date: 2025-12-25 @ 1:03 AM
Ignite Modification Date: 2026-02-23 @ 4:54 AM
Study NCT ID: NCT02764593
Status: COMPLETED
Last Update Posted: 2022-11-29
First Post: 2016-05-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety Testing of Adding Nivolumab to Chemotherapy in Patients With Intermediate and High-Risk Local-Regionally Advanced Head and Neck Cancer
Sponsor: RTOG Foundation, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Head and Neck Squamous Cell Carcinoma (HNSCC) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Head and Neck Squamous Cell Carcinoma View
None HNSCC View
None Nivolumab View